HALO logo
halo search icon
MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc.
MPLT · NAS

MapLight Therapeutics, Inc.

US$27.81

Price Arrow0.73 (2.70%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Price MomentumRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

MapLight Therapeutics, Inc. Overview

MPLT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About MPLT

icon

Website

MapLight Therapeutics, Inc.

icon

Telephone

1.617.984.6300

icon

Address

800 Chesapeake Drive, Redwood City, CA 94063

Description

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.

MPLT Price Chart

Key Stats

Market Cap

US$1.15B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 12.24 - 33.28

Trade Value (12mth)

US$833,182.00

1 week

-5.74%

1 month

-1.96%

YTD

61.48%

1 year

0%

All time high

33.28

Key Fundamentals

EPS 3 yr Growth

405.20%

EBITDA Margin

0.00%

Operating Cashflow

-$138m

Free Cash Flow Return

-47.30%

ROIC

-55.20%

Interest Coverage

0.00

Quick Ratio

20.00

Other Data

Shares Outstanding (Fully Diluted)

45m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

MPLT Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
15 May 26
15 May 26
15 May 26

MPLT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.34-1.87-3.66locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.34-1.87-3.66locklocklock
Growth
%locklocklocklock-85.6-39.3-95.5locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of MapLight Therapeutics, Inc. (MPLT:NAS)?
Halo FAQ
The current share price of MapLight Therapeutics, Inc. (MPLT:NAS) is USD$27.81.
What is the 52-week high share price for MapLight Therapeutics, Inc. (MPLT:NAS)?
Halo FAQ
The 52-week high share price for MapLight Therapeutics, Inc. (MPLT:NAS) is USD$33.28.
What is the 52-week low share price for MapLight Therapeutics, Inc. (MPLT:NAS)?
Halo FAQ
The 52-week low share price for MapLight Therapeutics, Inc. (MPLT:NAS) is USD$12.24.
What is the dividend yield for MapLight Therapeutics, Inc. (MPLT:NAS)?
Halo FAQ
MapLight Therapeutics, Inc. (MPLT:NAS) does not pay a dividend.
What was MapLight Therapeutics, Inc. (MPLT:NAS) last dividend payment?
Halo FAQ
MapLight Therapeutics, Inc. (MPLT:NAS) does not pay a dividend.
What is the franking level for MapLight Therapeutics, Inc. (MPLT:NAS)?
Halo FAQ
MapLight Therapeutics, Inc. (MPLT:NAS) has a franking level of 0.00%.
In which sector is MapLight Therapeutics, Inc. (MPLT:NAS) classified?
Halo FAQ
MapLight Therapeutics, Inc. (MPLT:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.